Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

被引：0

作者：

Jiří Pavlů

Myriam Labopin

Riitta Niittyvuopio

Gerard Socié

Ibrahim Yakoub-Agha

Depei Wu

Peter Remenyi

Jakob Passweg

Dietrich W. Beelen

Mahmoud Aljurf

Nicolaus Kröger

Hélène Labussière-Wallet

Zinaida Perić

Sebastian Giebel

Arnon Nagler

Mohamad Mohty

机构：

[1] Imperial College London at Hammersmith Hospital,Centre for Haematology

[2] EBMT Paris Study Office/CEREST-TC/Saint Antoine Hospital,Department of Haematology

[3] HUCH Comprehensive Cancer Center,Stem Cell Transplantation Unit

[4] Saint Louis Hospital,Hematology–BMT

[5] Hopital Claude Huriez,Service des Maladies du Sang

[6] CHRU Lille,Department of Hematology

[7] the First Affiliated Hospital of Soochow University,Department of Bone Marrow Transplantation

[8] Délpesti Centrumkórház–Országos Hematológiai és Infektológiai Intézet,Department of Oncology

[9] University Hospital Basel,Bone Marrow Transplantation Centre

[10] University Hospital of Essen,Service d’hématologie

[11] King Faisal Specialist Hospital and Research Center,Zavod za hematologiju

[12] University Hospital Eppendorf,Division of Hematology and Bone Marrow Transplantation

[13] Centre Hospitalier Lyon Sud,undefined

[14] Klinika za unutarnje bolesti,undefined

[15] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined

[16] Chaim Sheba Medical Center,undefined

[17] Tel-Hashomer and Sackler School of Medicine,undefined

来源：

Journal of Hematology & Oncology | / 12卷

关键词：

Measurable residual disease; Allogeneic hematopoietic cell transplantation; Acute lymphoblastic leukemia; Allogeneic; Myeloablative conditioning; Total body irradiation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
Giebel, Sebastian
Labopin, Myriam
Socie, Gerard
Aljurf, Mahmoud
Salmenniemi, Urpu
Labussiere-Wallet, Helene
Srour, Micha
Kroeger, Nicolaus
Al Zahrani, Mohsen
Lioure, Bruno
Remenyi, Peter
Arat, Mutlu
Bourhis, Jean Henri
Helbig, Grzegorz
Tbakhi, Abdelghani
Forcade, Edouard
Huynh, Anne
Brissot, Eolia
Spirydonidis, Alexandros
Savani, Bipin N.
Peric, Zinaida
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2023, 58 (05) : 506 - 513
[22] Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
Sebastian Giebel
Myriam Labopin
Gerard Socié
Mahmoud Aljurf
Urpu Salmenniemi
Hélène Labussière-Wallet
Micha Srour
Nicolaus Kröger
Mohsen Al Zahrani
Bruno Lioure
Péter Reményi
Mutlu Arat
Jean Henri Bourhis
Grzegorz Helbig
Abdelghani Tbakhi
Edouard Forcade
Anne Huynh
Eolia Brissot
Alexandros Spirydonidis
Bipin N. Savani
Zinaida Peric
Arnon Nagler
Mohamad Mohty
Bone Marrow Transplantation, 2023, 58 : 506 - 513
[23] Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT
Zinaida Peric
Myriam Labopin
Christophe Peczynski
Emmanuelle Polge
Jan Cornelissen
Ben Carpenter
Mike Potter
Ram Malladi
Jenny Byrne
Harry Schouten
Nathalie Fegueux
Gerard Socié
Montserrat Rovira
Jurgen Kuball
Maria Gilleece
Sebastian Giebel
Arnon Nagler
Mohamad Mohty
Bone Marrow Transplantation, 2020, 55 : 1560 - 1569
[24] Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party
Bazarbachi, Abdul Hamid
Al Hamed, Rama
Labopin, Myriam
Afanasyev, Boris
Hamladji, Rose-Marie
Beelen, Dietrich
Eder, Matthias
Scheid, Christof
Wu, Depei
Bunjes, Donald
Stepensky, Polina
Tischer, Johanna
Kroeger, Nicolaus
Peric, Zina
Aljurf, Mahmoud
Giebel, Sebastian
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 595 - 602
[25] Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party
Abdul Hamid Bazarbachi
Rama Al Hamed
Myriam Labopin
Boris Afanasyev
Rose-Marie Hamladji
Dietrich Beelen
Matthias Eder
Christof Scheid
Depei Wu
Donald Bunjes
Polina Stepensky
Johanna Tischer
Nicolaus Kröger
Zina Peric
Mahmoud Aljurf
Sebastian Giebel
Arnon Nagler
Mohamad Mohty
Bone Marrow Transplantation, 2020, 55 : 595 - 602
[26] Allogeneic stem cell transplantation (allo-SCT) with sequential conditioning in patients with relapsed/refractory acute lymphoblastic leukemia: A report from EBMT acute leukemia working party
Bazarbachi, Abdul Hamid
Al Hamed, Rama
Myriam, Labopin
Afanasyev, Boris
Hamladji, Rose-Marie
Dietrich, Beelen
Arnold, Ganser
Christof, Scheid
Wu Depei
Donald, Bunjes
Stepensky, Polina
Tischer, Johanna
Kroeger, Nicolaus
Peric, Zina
Giebel, Sebastian
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2019, 54 : 152 - 152
[27] Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)
Enrico Maffini
Myriam Labopin
Dietrich Wilhelm Beelen
Nicolaus Kroeger
Mutlu Arat
Keith M. O. Wilson
Jacques-Olivier Bay
Arnold Ganser
Hans Martin
Jakob Passweg
Panagiotis D. Kottaridis
Ibrahim Yakoub-Agha
Rocio Parody Porras
Eva Maria Wagner
Jordi Esteve
Francesco Lanza
Arnon Nagler
Mohamad Mohty
Bone Marrow Transplantation, 2022, 57 : 1556 - 1563
[28] Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)
Maffini, Enrico
Labopin, Myriam
Beelen, Dietrich Wilhelm
Kroeger, Nicolaus
Arat, Mutlu
Wilson, Keith M. O.
Bay, Jacques-Olivier
Ganser, Arnold
Martin, Hans
Passweg, Jakob
Kottaridis, Panagiotis D.
Yakoub-Agha, Ibrahim
Porras, Rocio Parody
Wagner, Eva Maria
Esteve, Jordi
Lanza, Francesco
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1556 - 1563
[29] Trends in allogeneic stem cell transplantation outcomes for acute myeloid Leukemia patients. The experience of the Acute Leukemia Working Party of the EBMT
Canaani, Jonathan
Beohou, Eric
Labopidn, Myriam
Ghavamzadeh, Ardeshir
Beelen, Dietrich
Hamladji, Rose-Marie
Niederwieser, Dietger
Volin, Liisa
Markiewicz, Miroslaw
Arnold, Renate
Mufti, Ghulam
Ehninger, Gerhard
Socie, Gerard
Kroeger, Nicolaus
Mohty, Mohamad
Nagler, Arnon
BONE MARROW TRANSPLANTATION, 2018, 53 : 26 - 27
[30] Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
Spyridonidis, A.
Labopin, M.
Schmid, C.
Volin, L.
Yakoub-Agha, I.
Stadler, M.
Milpied, N.
Socie, G.
Browne, P.
Lenhoff, S.
Sanz, M. A.
Aljurf, M.
Mohty, M.
Rocha, V.
LEUKEMIA, 2012, 26 (06) : 1211 - 1217

← 1 2 3 4 5 →